Leaflet CLOPIDOGREL/ACID ACETILSALICILIC BILLEV 75mg / 75mg film-coated tablets
Indicated for: prevention of atherothrombotic events
Route of administration: oral
Substance: clopidogrel + acetylsalicylic acid (antiplatelet agents)
ATC: B01AC30 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)
This medicine may have important interactions with other medicines.
This medicine may affect the kidneys.
Use during pregnancy only on medical advice.
Use in children only as recommended in the leaflet or by a doctor.
This medicine may increase the risk of bleeding.
This medicine may increase the risk of ulcer or gastrointestinal bleeding.
Clopidogrel and acetylsalicylic acid (aspirin) are used in combination to prevent blood clots in patients at high risk of cardiovascular events, such as myocardial infarction, stroke, or unstable angina. This combination is commonly used in the treatment of acute coronary syndromes and after procedures such as coronary angioplasty with stent implantation.
Clopidogrel is an antiplatelet agent that inhibits platelet aggregation by blocking P2Y12 receptors on the surface of platelets. Acetylsalicylic acid is also an antiplatelet agent that works by inhibiting cyclooxygenase (COX-1), thereby reducing the production of thromboxane A2, a substance that promotes platelet aggregation. Together, these medications provide a synergistic antiplatelet effect, reducing the risk of blood clot formation.
While this combination is effective, its use requires caution. The most common side effects include an increased risk of bleeding, such as gastrointestinal bleeding or nosebleeds. Other side effects may include abdominal pain, nausea, or allergic reactions. It is important for patients to inform their doctor of any history of bleeding, gastric ulcers, or other conditions that may increase the risk of complications.
This combination should be used as directed by a doctor, and patients should adhere to the prescribed dosage. It is important to avoid concurrent use with other medications that increase the risk of bleeding, such as anticoagulants or other nonsteroidal anti-inflammatory drugs (NSAIDs). If signs of excessive bleeding or other severe side effects occur, immediate medical attention is necessary.
General data about CLOPIDOGREL/ACID ACETILSALICILIC BILLEV 75mg / 75mg
- Substance: clopidogrel + acetylsalicylic acid
- Date of latest medicines list: 01-01-2015
- Product code: W61283001
- Concentration: 75mg / 75mg
- Pharmaceutical form: film-coated tablets
- Quantity: 14
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for clopidogrel + acetylsalicylic acid
Concentrations available for clopidogrel + acetylsalicylic acid
- 75mg/100mg
- 75mg/75mg
- 90mg/50mg